Capitalmind
Capitalmind
Actionable insights on equities, fixed-income, macros and personal finance Start 14-Days Free Trial
Actionable investing insights Get Free Trial

207 ArticlesPremium Portfolio

17 / 21

Optionalysis: MA20 Disappoints, But a Chart Pattern Shows a Potential Short-Term Reversal

 ...

Optionalysis: Finally the MA20 Turns, Giving a Glimmer of Hope For Options

 ...

Optionalysis: When Buying Straddles Fail – TCS Fell 4% But Option Sellers Still Took Home The Moolah

 ...

Optionalysis: What does "Short Covering" Really Mean?

Firstly, we’d like to announce that we raised a round of seed funding for Capital Mind. Thanks very much for all your support and we hope to bring you ...

Optionalysis: Ranbaxy April Futures Will Expire on April 01 on Merger With Sun Pharma, Things to Note

 ...

Optionalysis: Futures Premiums Are Through The Roof, While MA20 Starts Getting Interesting Finally

 ...

Optionalysis: The MA20 Sits On The Borderline, Action Time!

This is a post on Optionalysis for Capital Mind Premium subscribers ...

Optionalysis: MA20 Reverses, But Watch Out For Holidays and Expiry

It might be time to set up money to buy those call options again, as the MA20, our Capital Mind Premium indicator, seems to reverse. Note: Also check the ...

Optionalysis: The CAPM MA20 Shows Another Outlier Trigger

The CAPM MA20 Indicator has gone south, indicating a potential move down in the near future. It is constructed by taking the number of Nifty stocks above ...

Optionalysis: Making Money When Markets Fall

The market’s falling, eh? So what, says the trader. What difference does it make, if money can be made? Making money from falling markets is almost ...